PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
356601-4	1978	Plasma insulin levels similarly did not increase in the placebo but significantly rose in the ritodrine group by 30 minutes, peaked at 2 1/2 hours, and remained elevated throughout the infusion.	Ritodrine	94-103	insulin	Homo sapiens	7-14	
2864408-4	1985	There was a progressive rise in plasma glucose concentration and plasma insulin concentration during ritodrine hydrochloride infusion compared with the control (saline) infusion.	Ritodrine	101-124	insulin	Homo sapiens	72-79	
2864408-6	1985	The ritodrine hydrochloride-infused animals had a progressive rise in [insulin/glucose] compared with our prior studies in the newborn lamb, suggesting direct stimulation of pancreatic beta cell secretion.	Ritodrine	4-27	insulin	Homo sapiens	71-78	
3883263-0	1985	Metabolic disturbances during intravenous use of ritodrine: increased insulin levels and hypokalemia.	Ritodrine	49-58	insulin	Homo sapiens	70-77	
203880-3	1978	Ritodrine was more potent than isoxsuprine in increasing the circulating levels of cyclic AMP, glucose, insulin, and triglycerides.	Ritodrine	0-9	insulin	Homo sapiens	104-111	
851767-0	1977	Insulin requirements in pregnant diabetics with premature labour controlled by ritodrine.	Ritodrine	79-88	insulin	Homo sapiens	0-7	
31124960-6	2019	As an individual drug, ritodrine (24.4%) was the most frequently reported, followed by morphine, 5-HT3 serotonin antagonist, nefopam, fentanyl, magnesium sulfate, insulin lispro, cefazedone, sodium chloride, hydromorphone, oxycodone, cefotetan, nifedipine, human insulin, tramadol, ketorolac, pethidine, methylergometrine, metoclopramide, and misoprostol (in that order).	Ritodrine	23-32	insulin	Homo sapiens	263-270	
26510662-9	2016	Women treated with ritodrine hydrochloride needed more insulin, than those without ritodrine hydrochloride treatment (130.8 +- 15.0 vs. 76.8 +- 15.2 units/day, respectively, p < 0.05).	Ritodrine	19-42	insulin	Homo sapiens	55-62